Happy Tuesday! Alex Clavel, the top boss at SoftBank Vision Fund, spoke to ETtech in an exclusive interview. This and more in today’s ETtech Morning Dispatch. Alex Clavel, co-CEO of SoftBank ...
or ST-920, its wholly owned gene therapy product candidate for the treatment of Fabry disease. The FDA has agreed in a Type B interaction that data from the ongoing Phase 1/2 STAAR study can serve ...
The Chan Zuckerberg Initiative (CZI) and SoftBank led a $150 million investment round for the Indian ed-tech unicorn Eruditus, which strengthened its financial position in the cutthroat education ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback